Overview
ABsize Inc. is a nanotechnology / nanomedicine company. Using its proprietary technology platform, Laser-induced Nanolization Technology (LiNTEC), ABsize is developing a novel nano-drug product pipeline, and partnering with pharma / biotech companies to developing their new products. LiNTEC is a non-thermal and non-contact physical process to nanolize poorly water-soluble molecules without chemical change, thereby increasing water solubility, improving bioavailability, and creating new formulations and delivery route.
Management Team
Founder/CTO
Isamu Oh, Ph.D.,
LiNTEC inventor,
professor of Osaka University;
co-founder of Hanaphi and Neubrex.
CEO
CJ Wang, Ph.D.,
former VP
Bus Dev of VIVUS, Abmaxis and
TaiGen Biotech; VP Marketing
and Bus Dev of Cellomics; Dir.
Licensing & Acquisition,
Packard Bioscience.
CFO
Annie
Ma,
chairman/founder
of Ample Luck International Capital
Group, a boutique merchant bank;
Co-founder of Hansun Tech.
Company Profile
![]()
| Company Name | ABsize Inc. |
|---|---|
| Foundation | Jan 10th, 2007 |
| Our Office | 10 S. Third St, 3rd Floor,
San Jose CA, 95113, USA Tel. 1-408-351-3453 Fax. 1-408-521-0286 |
| Japan Office | S-cube 104, 130-42, Nagasone-cho, Kita-ku, Sakai-shi, Osaka, 591-8025, Japan →Access Map |
| CEO | CJ Wang, Ph.D. |
| Founder/CTO | Isamu Oh. Ph.D. |
| CFO | Annie Ma |
| Director | Teruki Sugiyama |
| Director | CJ Wang Ph.D. |
| Auditor | Yoshimaro Ito |
| Scientific Officer | Dr. Hiroshi Masuhara Professor
Emeritus of Osaka Univeristy Dr. Hideki Yoshikawa Chairman and Professor, Department of Orthopaedics, Osaka University Graduate School of Medicine Dr. Noriyuki Tsumaki, M.D. Osaka University Graduate School of Medicine |
| Business Supporters | Kirkpatrick & Lockhart
Preston Gates Ellis LLP Matsumoto & Associates |
| Current Investor VCs | Nippon Venture Capital, Future Venture Capital, Angel Capital, and Resona Capital, Co., Ltd. |
